SLC3A2 and B-cell chronic lymphocytic leukemia: Regarding biological CLL parameters, unmutated immunoglobulin heavy-chain variable region gene (IGHV) status, stereotyped IGHV frames, and unfavorable cytogenetics represented by chromosome 17p and/or 11q deletions and nine down-regulated miRNAs are risk factors for developing AIHA in the context of CLL [7,18].